AzTrials
AzTrials

Forearm InjuriesFORESTNCT07536581

Time to Healing in Displaced Pediatric Diaphyseal Forearm Fractures Treated With Bioabsorbable Compared to Titanium Intramedullary Nails

A study testing Bioabsorbable intramedullary nail and Titanium elastic intramedullary nail in people with Forearm Injuries and Radius Fractures, run by Children's Fractures Interest Group, Denmark at 1 site in Denmark.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study looks at children with forearm fractures that need surgery. The standard treatment uses titanium nails, which usually need to be removed in a second operation later. This study compares titanium nails with bioabsorbable nails, which gradually dissolve in the body and may help some children avoid another… Read more about this study

Who is it for?
Ages 3 to 13 years
Conditions the study is for
Forearm Injuries, Radius Fractures, Ulna Fractures
What is being tested?
Bioabsorbable intramedullary nail and Titanium elastic intramedullary nail
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteDenmark
Study dates
Apr 2026to Dec 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Diagnosis of a traumatic diaphyseal forearm fracture of the radius, ulna, or both
  • Operative fixation required
  • Fractures must be complete (not unicortical or greenstick) AND displaced >50% of bone width (after attempted closed reduction) AND/OR angulated >10° in any plane (after attempted closed reduction)
  • Informed consent obtained

Who cannot join

  • Conditions where internal fixation is contraindicated (e.g. active or potential infection)
  • Grossly open fractures (Gustilo Anderson grade > 2)
  • Fracture occurred more than 2 weeks prior
  • Fractures that are well managed conservatively (undisplaced or minimally displaced)
  • Previous ipsilateral forearm fracture (risk of closed medullary canal)
  • Fractures unsuited for intramedullary nailing (e.g. multifragmentary, metaphyseal or epiphyseal)
Show all 15Show fewer
  • Concurrent ipsilateral wrist or elbow involvement (e.g. Monteggia or Galeazzi variants)
  • Unable to participate in follow-up
  • Existing bone pathology (e.g. tumor, osteogenesis imperfecta, degenerative disease)
  • Participation in any other medical device or medicinal product study within the previous month that could influence in opinion of the PI the results of the present study
  • Intraoperative exclusion criteria:
  • Fractures suitable for closed reduction and casting (see 6.3.9)
  • Indication for treatment 1 (BIN) only
  • Indication for treatment 2 (ESIN) only
  • Intraoperative decision to use implants other than the devices under investigation

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Denmark1 site
  • Copenhagen University Hospital - Herlev

    København NV, 2400

    Morten J Andersen, MD, 004526148624, mortenjonandersen@gmail.com

    Morten J Andersen, MD

Other trials in Denmark

About this study

Official title: Time to Healing in Displaced Pediatric Diaphyseal Forearm Fractures Treated With Bioabsorbable Compared to Titanium Intramedullary Nails: A Single-Center, Multi-Blinded, Randomized Parallel-Group, Non-Inferiority Study

This study looks at children with forearm fractures that need surgery. The standard treatment uses titanium nails, which usually need to be removed in a second operation later. This study compares titanium nails with bioabsorbable nails, which gradually dissolve in the body and may help some children avoid another operation.

The study will compare how quickly the fractures heal on X-ray, and also look at complications, recovery, function, and the family's experience. Children who need surgery will be randomly assigned to one of the two treatments so the comparison is fair.

Hypothesis: The researchers expect that fractures treated with bioabsorbable nails will heal almost as quickly as fractures treated with titanium nails, while reducing the need for later implant removal surgery.

Read the detailed description

This clinical study will examine the treatment of displaced forearm fractures in children. Forearm fractures are very common in childhood. Most can be treated with a cast alone, but some fractures are too unstable or too badly displaced and need an operation to hold the bones in the correct position while they heal. In this study, we compare two types of intramedullary nails, which are thin rods placed inside the bone during surgery to stabilize the fracture. One type is made of titanium, which is the current standard treatment. The other type is bioabsorbable, which means it gradually dissolves in the body over time.

The main reason for studying the bioabsorbable nail is that it may allow children to avoid a second planned operation. In Denmark, titanium nails are usually removed in a later procedure, often 6 to 12 months after the first surgery. Even though that removal operation is generally safe, it still means another hospital visit, another anesthetic, another recovery period, and additional stress for the child and family. A dissolving nail could reduce this burden. However, because bioabsorbable nails are more flexible than titanium nails, there is a concern that the bone may heal a little more slowly.

The study will include children aged 3 to 13 years who have a displaced fracture in the shaft of one or both forearm bones and who need surgical treatment. Children who take part will be randomly assigned to one of two treatment groups. One group will receive a bioabsorbable nail and a cast for 4 weeks. The other group will receive a titanium nail and a cast for 2 weeks. The allocation is random so the two groups can be compared fairly. Families, the clinicians doing follow-up assessments, and the people evaluating the X-rays will, as far as possible, not know which type of nail the child received.

The main outcome in the study is how long it takes for the fracture to heal on X-ray. The study will also compare the two groups with respect to complications, pain, arm function, return to normal activities, and the child's and family's experience during recovery. The children will attend planned follow-up visits with clinical examinations and X-rays over time so the researchers can assess healing and safety in a standardized way.

Hypothesis:

The study hypothesis is that children treated with bioabsorbable intramedullary nails will have a healing time on X-ray that is not unacceptably longer than children treated with titanium nails. In other words, the researchers expect the bioabsorbable nail to provide nearly the same healing result as the titanium nail, while offering the important advantage that many children may avoid a second operation to remove the implant.

Being tested
Bioabsorbable intramedullary nail, Titanium elastic intramedullary nail
Keywords
Randomized Controlled Trial (RCT), pediatric forearm fracture, forearm shaft fracture in children, elastic stable intramedullary nailingelastic stable intramedullary nailing, ESIN, titanium elastic nail, bioabsorbable intramedullary nail, TEN, BIN, radiographic healing, radiographic union, modified Radiographic Union Score, mRUS, non-inferiority trial, randomized trial
Medical subject headings
Forearm Injuries, Radius Fractures, Ulna Fractures, Fractures, Bone

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bioabsorbable intramedullary nailDevice

    Also called Activa IM-Nail™

    Bioabsorbable intramedullary: Surgical fixation of the forearm fracture with a bioabsorbable intramedullary nail made of PLGA (poly[lactic-co-glycolic acid]), performed under general anesthesia, followed by above-elbow cast immobilization for 4 weeks. The implant is designed to retain strength during early healing and gradually absorb over time, so routine implant removal is not planned.

  • Titanium elastic intramedullary nailDevice

    Also called Titanium Elastic Nail System, TEN

    Titanium elastic intramedullary nail arm: surgical fixation of the forearm fracture with a titanium elastic intramedullary nail, performed under general anesthesia, followed by above-elbow cast immobilization for 2 weeks. In Denmark, later elective implant removal is standard practice.

Study groups in NCT07536581
Study groupRoleWhat they receive
Bioabsorbable intramedullary nail (BIN)ExperimentalChildren in this arm receive surgical fixation with a bioabsorbable intramedullary nail, followed by above-elbow cast immobilization for 4 weeks.
Receives: Device: Bioabsorbable intramedullary nail
Titanium elastic nail (TEN)Active comparatorChildren in this arm receive surgical fixation with a titanium elastic intramedullary nail, followed by above-elbow cast immobilization for 2 weeks.
Receives: Device: Titanium elastic intramedullary nail

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to fracture healing (weeks)

    Time in weeks from surgery/randomization (Day 0) to the first postoperative radiographic assessment meeting the predefined healing threshold, assessed using the modified Radiographic Union Score (mRUS). Healing is defined as mRUS ≥11, with bridging callus present in at least 3 of 4 cortices and no cortex scored 1; for both-bone fractures, both bones must meet this threshold at the same assessment.

    Measured: Postoperative radiographic assessments at 2, 4, and 6 weeks; if healing has not yet been established, additional radiographic assessments at 8 and 10 weeks, until the healing threshold is reached.

Secondary outcomes (1)
  1. Range of motion

    Active motion of the elbow, forearm, and wrist measured in degrees with a goniometer.

    Measured: From surgery/randomization (Day 0) to scheduled follow-up assessments at 2, 4, 6, and 12 weeks, and at 6 months, 1 year, and 2 years; if healing is delayed, also at 8 and 10 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2026
  2. Study startApr 2026 (estimated)
  3. Primary completionMay 2031 (estimated)
  4. Study completionDec 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a single-center, randomized, parallel-group, blinded, non-inferiority interventional trial. Children aged 3-13 years with displaced diaphyseal forearm fractures requiring operative fixation are randomized 1:1 to one of two active surgical treatment arms: bioabsorbable intramedullary nails or titanium elastic nails. The trial compares these two standardized operative strategies to determine whether time to radiographic healing with bioabsorbable nails is non-inferior to titanium nails. The design includes age stratification and equal allocation between groups.
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07536581
Sponsor's protocol ID
16-0302-99
Acronym
FOREST
Status last verified
Apr 2026
First submitted
11 Apr 2026
Last updated
22 Apr 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: De-identified individual participant data collected during this study will not be made publicly available. Due to the small sample size, single-center design, and pediatric population, there is a relevant risk of participant re-identification even after de-identification. Aggregate study results will be reported in publications and presentations.

Publications

  • Korhonen L, Perhomaa M, Kyro A, Pokka T, Serlo W, Merikanto J, Sinikumpu JJ. Intramedullary nailing of forearm shaft fractures by biodegradable compared with titanium nails: Results of a prospective randomized trial in children with at least two years of follow-up. Biomaterials. 2018 Dec;185:383-392. doi: 10.1016/j.biomaterials.2018.09.011. Epub 2018 Sep 11.

    PubMed 30292588
  • Simanovsky N, Tair MA, Simanovsky N, Porat S. Removal of flexible titanium nails in children. J Pediatr Orthop. 2006 Mar-Apr;26(2):188-92. doi: 10.1097/01.bpo.0000218534.51609.aa.

    PubMed 16557132
  • Lascombes P, Haumont T, Journeau P. Use and abuse of flexible intramedullary nailing in children and adolescents. J Pediatr Orthop. 2006 Nov-Dec;26(6):827-34. doi: 10.1097/01.bpo.0000235397.64783.d6.

    PubMed 17065959

Questions about this trial

What is this clinical trial studying?

A study testing Bioabsorbable intramedullary nail and Titanium elastic intramedullary nail in people with Forearm Injuries and Radius Fractures, run by Children's Fractures Interest Group, Denmark at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 22 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to fracture healing (weeks) (time frame: Postoperative radiographic assessments at 2, 4, and 6 weeks; if healing has not yet been established, additional radiographic assessments at 8 and 10 weeks, until the healing threshold is reached.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07536581, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in